Share

Results of temperature-controlled radiofrequency tissue volume reduction for the turbinate hypertrophy.

Prakobkiat Hirunwiwatkul, Songklot Aeumjaturapata, Pornchai Oraphin

PAPERpubmedJournal of the Medical Association of Thailand = Chotmaihet thangphaet2004randomized trialEffect: benefitEvidence: Low

Abstract

OBJECTIVES: To assess the efficacy of temperature-controlled radiofrequency tissue volume reduction (RFTVR) for the inferior turbinate. RESEARCH DESIGNS: Prospective, single-blinded, experimental clinical trial. METHOD: Twenty patients with nasal obstruction secondary to inferior turbinate hypertrophy were enrolled. Nasal obstruction was compared between before and after the treatment (at 1-3 days, 1 week and 6-8 weeks) of RFTVR using subjective symptom scores, physical findings and videotape images. RESULTS: Improvement of nasal symptoms was observed as early as 1 week after the operation. However, significant improvement was obtained at 6-8 weeks. CONCLUSION: RFTVR for the turbinate may be useful as an alternative approach for the treatment of chronic turbinate hypertrophy.

AI evidence extraction

At a glance
Study type
randomized trial
Effect direction
benefit
Population
Patients with nasal obstruction secondary to inferior turbinate hypertrophy
Sample size
20
Exposure
RF
Evidence strength
Low
Confidence: 74% · Peer-reviewed: yes

Main findings

Nasal symptom improvement was observed as early as 1 week after radiofrequency tissue volume reduction, with significant improvement at 6–8 weeks post-treatment.

Outcomes measured

  • Nasal obstruction/nasal symptoms (subjective symptom scores)
  • Physical findings
  • Videotape image assessment

Limitations

  • Small sample size (n=20)
  • Single-blinded design
  • Follow-up limited to 6–8 weeks
  • No RF exposure parameters (e.g.
  • frequency
  • dose) reported in abstract
View raw extracted JSON
{
  "study_type": "randomized_trial",
  "exposure": {
    "band": "RF",
    "source": "medical procedure (radiofrequency tissue volume reduction)",
    "frequency_mhz": null,
    "sar_wkg": null,
    "duration": null
  },
  "population": "Patients with nasal obstruction secondary to inferior turbinate hypertrophy",
  "sample_size": 20,
  "outcomes": [
    "Nasal obstruction/nasal symptoms (subjective symptom scores)",
    "Physical findings",
    "Videotape image assessment"
  ],
  "main_findings": "Nasal symptom improvement was observed as early as 1 week after radiofrequency tissue volume reduction, with significant improvement at 6–8 weeks post-treatment.",
  "effect_direction": "benefit",
  "limitations": [
    "Small sample size (n=20)",
    "Single-blinded design",
    "Follow-up limited to 6–8 weeks",
    "No RF exposure parameters (e.g., frequency, dose) reported in abstract"
  ],
  "evidence_strength": "low",
  "confidence": 0.74,
  "peer_reviewed_likely": "yes",
  "keywords": [
    "radiofrequency",
    "temperature-controlled",
    "tissue volume reduction",
    "inferior turbinate",
    "turbinate hypertrophy",
    "nasal obstruction",
    "clinical trial"
  ],
  "suggested_hubs": []
}

AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract/metadata and may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.

Comments

Log in to comment.

No comments yet.

NNEMF synthesis

Synthesis pending.

Original record: rfsafe.org paper 3641

Results of temperature-controlled radiofrequency tissue volume reduction for the turbinate hypertrophy. · Non-native EMF